Chemtura Corporation CHMT today announced it has
entered into an asset purchase agreement to sell its Antioxidant and UV
Stabilizers business, including dedicated manufacturing plants in the U.S,
France, and Germany, to an affiliate of SK Capital Partners, for $200 million
and the assumption of certain liabilities. The purchase price is subject to a
post-closing net working capital adjustment. The transaction is subject to
customary closing conditions. Proceeds from the sale will be used for
repayment of debt and investment in Chemtura's continued growth. The
transaction is expected to close by the end of 2012 or in early 2013.
“This divestiture simplifies our business portfolio as we continue to invest
in businesses with less economic sensitivity that make greater contributions
to our strategy of focusing on specialty products and applications with
greater growth potential in our strategic industry segments and in
faster-growing regions,” said Craig A. Rogerson, Chemtura Chairman, President
and CEO. “The purchase price for the Antioxidant and UV Stabilizers business
represents a 6.4X multiple on adjusted EBITDA for the 12 months ended Sept.
30, 2012. The revenues of the business in the same period were approximately
$390 million.”
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in